U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 91 - 100 of 157 results

Protein
Status:
Investigational
Source:
INN:pagibaximab [INN]
Source URL:

Class:
PROTEIN

Lusupultide is a genetically engineered surfactant preparation containing recombinant surfactant protein C (rSP-C) embedded in a phospholipid matrix. It reduces surface tension and keeps the alveoli open, thus ensuring a stable surface for oxygen passage. Lusupultide had got orphan designations from EMA for the treatment of acute respiratory distress syndrome and aspiration pneumonitis requiring intubation and mechanical ventilation. Lusupultide development has been discontinued.